| Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 GG Global Burden of Disease Cancer Collaboration, Fitzmaurice C | 6657* | |
| Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 | 5449* | |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 T Vos, SS Lim, C Abbafati, KM Abbas, M Abbasi, M Abbasifard, ... The Lancet 396 (10258), 1204-1222, 2020 | 3392 | 2020 |
| Global burden of 87 risk factors in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 CJL Murray, AY Aravkin, P Zheng, C Abbafati, KM Abbas, ... The lancet 396 (10258), 1223-1249, 2020 | 2812 | 2020 |
| Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019 C Abbafati, DB Machado, B Cislaghi, OM Salman, M Karanikolos, ... The Lancet 396 (10258), 1204-1222, 2020 | 502 | 2020 |
| Five insights from the global burden of disease study 2019 CJL Murray, C Abbafati, KM Abbas, M Abbasi, M Abbasi-Kangevari, ... The Lancet 396 (10258), 1135-1159, 2020 | 393 | 2020 |
| The global, regional, and national burden of pancreatic cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … A Pourshams, SG Sepanlou, KS Ikuta, C Bisignano, S Safiri, G Roshandel, ... The lancet Gastroenterology & hepatology 4 (12), 934-947, 2019 | 327 | 2019 |
| The global, regional, and national burden of stomach cancer in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease study 2017 A Etemadi, S Safiri, SG Sepanlou, K Ikuta, C Bisignano, R Shakeri, ... The lancet Gastroenterology & hepatology 5 (1), 42-54, 2020 | 319 | 2020 |
| Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019: a systematic analysis … JM Kocarnik, K Compton, FE Dean, W Fu, BL Gaw, JD Harvey, ... JAMA oncology 8 (3), 420-444, 2022 | 268 | 2022 |
| The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … S Safiri, SG Sepanlou, KS Ikuta, C Bisignano, H Salimzadeh, A Delavari, ... The lancet Gastroenterology & hepatology 4 (12), 913-933, 2019 | 238 | 2019 |
| Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic … MB Reitsma, PJ Kendrick, E Ababneh, C Abbafati, M Abbasi-Kangevari, ... The Lancet 397 (10292), 2337-2360, 2021 | 222 | 2021 |
| Analysis of latency time and its determinants in asbestos related malignant mesothelioma cases of the Italian register A Marinaccio, A Binazzi, G Cauzillo, D Cavone, R De Zotti, P Ferrante, ... European journal of cancer 43 (18), 2722-2728, 2007 | 176 | 2007 |
| Mapping 123 million neonatal, infant and child deaths between 2000 and 2017 R Burstein, NJ Henry, ML Collison, LB Marczak, A Sligar, S Watson, ... Nature 574 (7778), 353-358, 2019 | 173 | 2019 |
| The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the … F Kamangar, D Nasrollahzadeh, S Safiri, SG Sepanlou, C Fitzmaurice, ... The lancet Gastroenterology & hepatology 5 (6), 582-597, 2020 | 163 | 2020 |
| Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age‐period‐cohort models A Marinaccio, F Montanaro, M Mastrantonio, R Uccelli, P Altavista, ... International Journal of Cancer 115 (1), 142-147, 2005 | 154 | 2005 |
| Environmental tobacco smoke exposure in public places of European cities M Nebot, MJ Lopez, G Gorini, M Neuberger, S Axelsson, M Pilali, ... Tobacco control 14 (1), 60-63, 2005 | 150 | 2005 |
| Occupation and occupational exposure to endocrine disrupting chemicals in male breast cancer: a case–control study in Europe S Villeneuve, D Cyr, E Lynge, L Orsi, S Sabroe, F Merletti, G Gorini, ... Occupational and environmental medicine 67 (12), 837-844, 2010 | 104 | 2010 |
| Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients M Mangoni, S Bisanzi, F Carozzi, C Sani, G Biti, L Livi, E Barletta, ... International Journal Of Radiation Oncology* Biology* Physics 81 (1), 52-58, 2011 | 95 | 2011 |
| Quantifying risks and interventions that have affected the burden of diarrhoea among children younger than 5 years: an analysis of the Global Burden of Disease Study 2017 CE Troeger, IA Khalil, BF Blacker, MH Biehl, SB Albertson, SRM Zimsen, ... The Lancet Infectious Diseases 20 (1), 37-59, 2020 | 93 | 2020 |
| Tobacco smoking and COVID-19 pandemic: old and new issues. A summary of the evidence from the scientific literature MS Cattaruzza, V Zagà, S Gallus, P D’Argenio, G Gorini Acta Bio Medica: Atenei Parmensis 91 (2), 106, 2020 | 89 | 2020 |
giulia carrerasIstituto per lo Studio e la Prevenzione Oncologica - ISPODirección de correo verificada de ispo.toscana.it
